Home China Biotech In Review: Eli Lilly Joins The Big Pharmas Accused Of Bribing In China
 

Keywords :   


China Biotech In Review: Eli Lilly Joins The Big Pharmas Accused Of Bribing In China

2013-08-25 10:18:37| Biotech - Topix.net

MicuRx Pharmaceuticals, a San Francisco-Shanghai antibiotics company, raised $25 million in Series B financing.

Tags: review big china accused

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
06.10Atlantic Tropical Weather Outlook
06.10Tropical Storm Milton Graphics
06.10Tropical Storm Milton Public Advisory Number 3A
06.10Summary for Tropical Storm Milton (AT4/AL142024)
06.10Eastern North Pacific Tropical Weather Outlook
06.10Hurricane Leslie Graphics
06.10Hurricane Kirk Graphics
06.10Hurricane Leslie Forecast Discussion Number 15
More »